Skip to content

Application of the Recommendations of the SPLIF (French Society of Infectious Pathology) in a Geriatric Population on the Duration of Treatment for Bacterial Pneumonia

Duration of Antibiotic Treatment for Infectious Pneumonia in Eldery Subjects

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06307730
Enrollment
35
Registered
2024-03-13
Start date
2023-01-02
Completion date
2023-04-30
Last updated
2024-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia, Bacterial, Pneumopathy

Keywords

pneumopathy, Bacterial, nosocomial

Brief summary

Pneumopathy is the leading cause of death from infectious disease in the elderly. Prior to 2021, the recommended duration of antibiotic therapy for pneumonia, in adults, was 7 days. Two theses have shown that these recommendations were poorly applied in geriatric services. Indeed, the duration of treatment exceeded 7 days, and less than 30% of antibiotic antibiotic treatments were re-evaluated at 72 hours. In 2021, the SPLIF ( published new recommendations reducing this duration to 5 days in the event of clinical improvement observed on the 3rd day of treatment. These new recommendations are based on studies, in which the average age of participants was 65 years. However, the average age of patients in geriatric short-stay departments is 84.7 years. In addition, the geriatric population is characterized by immunosenescence, pulmonary vulnerability and undernutrition, raising questions about the validity of these recommendations in the geriatric population. The investigators offer a monocentric, retrospective, observational study of the geriatric hospital Casanova to assess the application of SPLIF recommendations in the geriatric population.

Interventions

None listed

Sponsors

Centre Hospitalier de Saint-Denis
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patient treated for bacterial/community/nosocomial pneumonia who stayed in the geriatric short-stay at Casanova's Hospital between January 2, 2023 and April 30, 2023

Exclusion criteria

* HIV Positif * Immunosupressed patient * Complicated pneumonia (abcess, pleuropneumonia)

Design outcomes

Primary

MeasureTime frameDescription
SexDay 1
AgeDay 1
WeightDay 1
Phone NumberDay 1
OriginsDay 1Coming from Home, An institution...
Autonomy in daily life's score before hospitalisationDay 1score between 0 (autonomous) and 6 (dependent)
Charlson's morbidity scoreDay 1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026